Sudhan DR, Guerrero-Zotano A, Won H, Gonzalez Ericsson P, et al. Hyperactivation of TORC1 Drives Resistance to the Pan-HER Tyrosine Kinase Inhibitor Neratinib in HER2-Mutant Cancers. Cancer Cell 2020;37:183-199.
PMID: 31978326